SMMT News & Analysis
3 articles
Market Mood
Summit Therapeutics (SMMT) Neutral Rating Reaffirmed by H.C. Wainwright
H.C. Wainwright has maintained a Neutral rating on Summit Therapeutics (SMMT). This rating indicates an expectation of limited near-term price movement for the stock. Analysts do not project significant changes in the company's performance based on current market conditions. Investors may want to keep track of any further updates or changes in analysts' assessments that could affect stock performance.
Read More: Summit Therapeutics (SMMT) Neutral Rating Reaffirmed by H.C. Wainwright
Electric Vehicles Cost 30% More to Repair Than Gas Models
Electric vehicles (EVs) cost an average of 30% more to repair compared to petrol or diesel cars. Repair times for EVs are also 14% longer. Consequently, insuring an EV can be 10-25% more expensive, depending on the model. These increased costs can deter potential buyers, particularly amid the rising demand for EVs, which constituted nearly one-third of new car sales in the UK as of June. For ordinary investors, understanding these dynamics is crucial as they affect consumer adoption and market growth in the EV sector.
Read More: Electric Vehicles Cost 30% More to Repair Than Gas Models
Convertible Sales Drop 90% in UK Over 20 Years
Sales of new convertible cars in the UK have decreased by 90% over the past two decades, falling from 109,171 units in 2005 to just 11,484 in 2022, according to the Society of Motor Manufacturers and Traders. This decline corresponds with the significant rise in popularity of SUVs, which represented 59% of car sales across Europe last year, according to Dataforce GmbH. The shift in consumer preferences towards practicality over style has contributed to the dwindling demand for convertibles. As a result, manufacturers are increasingly hesitant to produce new models given the costs associated with development and safety regulations.
Read More: Convertible Sales Drop 90% in UK Over 20 Years